Mitsubishi UFJ Trust & Banking Corp Trims Position in Cardinal Health, Inc. $CAH

Mitsubishi UFJ Trust & Banking Corp lowered its position in Cardinal Health, Inc. (NYSE:CAH) by 2.8% in the third quarter, HoldingsChannel reports. The firm owned 293,112 shares of the company’s stock after selling 8,597 shares during the period. Mitsubishi UFJ Trust & Banking Corp’s holdings in Cardinal Health were worth $46,007,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. SJS Investment Consulting Inc. grew its position in Cardinal Health by 1,363.6% in the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after acquiring an additional 150 shares during the period. Jones Financial Companies Lllp lifted its position in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after buying an additional 14,034 shares during the last quarter. Atlantic Edge Private Wealth Management LLC boosted its stake in Cardinal Health by 75.0% during the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after buying an additional 75 shares during the period. American Capital Advisory LLC increased its holdings in Cardinal Health by 5,200.0% in the 3rd quarter. American Capital Advisory LLC now owns 212 shares of the company’s stock valued at $33,000 after purchasing an additional 208 shares during the last quarter. Finally, Vermillion & White Wealth Management Group LLC grew its stake in shares of Cardinal Health by 55.0% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after buying an additional 71 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have commented on CAH. Barclays began coverage on shares of Cardinal Health in a research note on Monday, December 8th. They issued an “overweight” rating and a $243.00 price target for the company. Leerink Partners set a $240.00 target price on shares of Cardinal Health in a research report on Tuesday, January 13th. Robert W. Baird set a $250.00 target price on Cardinal Health in a research report on Wednesday, January 14th. Jefferies Financial Group lifted their price target on Cardinal Health from $220.00 to $270.00 and gave the stock a “buy” rating in a research report on Thursday. Finally, Citigroup upgraded Cardinal Health from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $190.00 to $244.00 in a research note on Friday, January 9th. Fourteen research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus target price of $221.07.

Cardinal Health Trading Up 0.7%

NYSE:CAH opened at $208.29 on Friday. Cardinal Health, Inc. has a 12-month low of $120.72 and a 12-month high of $215.48. The stock’s 50 day simple moving average is $205.78 and its 200-day simple moving average is $176.26. The firm has a market cap of $49.49 billion, a P/E ratio of 31.42, a PEG ratio of 1.41 and a beta of 0.65.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company had revenue of $64.01 billion for the quarter, compared to analysts’ expectations of $59.41 billion. During the same period in the previous year, the company posted $1.88 EPS. Cardinal Health’s revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Investors of record on Friday, January 2nd were issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend was Friday, January 2nd. Cardinal Health’s dividend payout ratio is currently 30.77%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.